Business
Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids
BOCA RATON, Fla., September 23, 2025--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces that a study published in Dermatologic Therapy demonstrates the safety and efficacy of the Company’s superficial radiotherapy (SRT) technology combined with punch excision to treat keloids.
About this update from Sensus Healthcare, Inc.
[{"type":"text","content":"BOCA RATON, Fla., September 23, 2025--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces that a study published in Dermatologic Therapy demonstrates the safety and efficacy of the Company’s superficial radiotherapy (SRT) technology combined with punch excision to treat keloids.","length":469,"tagName":"p"},{"type":"text","content":"The article, titled "Efficacy of Punch Excision Combined With Superficial X-Ray for the Treatment of Keloids: A Single-Center Retrospective Study," evaluates 60 patients treated with a combination of punch excision and superficial X-ray therapy at the Hospital for Skin Diseases in Nanjing, China. The punch excision better enables SRT penetration to induce fibroblast apoptosis, yielding a synergistic therapeutic effect. Results showed a statistically significant improvement in patient outcomes, with notable reductions in pain, itching, thickness and irregularity of keloid scars after one year of follow-up. No severe adverse reactions were reported, reinforcing the safety profile of SRT.","length":704,"tagName":"p"},{"type":"text","content":""This study by Junyou Zheng and colleagues is one of very few to examine punch excision combined with SRT, and it supports existing literature showing the benefits of our SRT technology in preventing keloid recurrence following surgical excision. The psychological impact of keloids is not to be underestimated, and this study underscores keloids as a serious medical condition that warrants access to treatment, including combination therapy with SRT," said Joe Sardano, Chairman and CEO of Sensus Healthcare. "Superficial radiotherapy has a long-standing record of safety, efficacy and patient satisfaction, and we believe studies such as this one will play an important role in shaping payer and policymaker understanding of the significant physical and emotional burden keloids place on patients."","length":821,"tagName":"p"},{"type":"text","content":""This study extends the safe and effective use of superficial radiation beyond post complete surgical keloid excision to following punch excision keloid debulking, allowing for treatment of multiple and ...